Comprehensive genome sequencing of the liver cancer genome.

[1]  Boping Zhou,et al.  Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma , 2012, Nature Genetics.

[2]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[3]  Robert M Hoffman,et al.  The challenges posed by cancer heterogeneity , 2012, Nature Biotechnology.

[4]  Keith A. Boroevich,et al.  Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators , 2012, Nature Genetics.

[5]  Angela M. Liu,et al.  Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma , 2012, Nature Genetics.

[6]  S. Imbeaud,et al.  Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma , 2012, Nature Genetics.

[7]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[8]  K. Polyak,et al.  Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.

[9]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[10]  Thomas D. Wu,et al.  The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. , 2012, Genome research.

[11]  Philippe P Roux,et al.  Regulation and function of the RSK family of protein kinases. , 2012, The Biochemical journal.

[12]  Tian-Li Wang,et al.  ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. , 2011, Cancer research.

[13]  Michael A Choti,et al.  Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma , 2011, Nature Genetics.

[14]  Christopher D. Brown,et al.  Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data , 2011, Proceedings of the National Academy of Sciences.

[15]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[16]  Hidenori Ojima,et al.  High-resolution characterization of a hepatocellular carcinoma genome , 2011, Nature Genetics.

[17]  Jannik N. Andersen,et al.  Cancer genomics: from discovery science to personalized medicine , 2011, Nature Medicine.

[18]  Lewis R. Roberts,et al.  Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.

[19]  E. Wagner,et al.  Mitogen‐inducible gene‐6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma , 2010, Hepatology.

[20]  Gary D Bader,et al.  International network of cancer genome projects , 2010, Nature.

[21]  Tom Royce,et al.  A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.

[22]  E. Birney,et al.  A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.

[23]  M. Hung,et al.  KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. , 2009, Molecular cell.

[24]  Derek Y. Chiang,et al.  Pathogenesis of hepatocellular carcinoma and molecular therapies , 2009, Current opinion in gastroenterology.

[25]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Maguire,et al.  Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing , 2009, Nature Biotechnology.

[27]  S. V. van Heeringen,et al.  The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response , 2008, Nucleic acids research.

[28]  Tsutomu Ohta,et al.  Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy , 2008, Proceedings of the National Academy of Sciences.

[29]  R. Reddel,et al.  Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells , 2008, Cancer science.

[30]  Takehide Asano,et al.  Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed‐lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma , 2008, Human mutation.

[31]  Ron Bose,et al.  Inhibition of the EGF Receptor by Binding to an Activating Kinase Domain Interface , 2007, Nature.

[32]  S. Hirohashi,et al.  Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. , 2007, Gastroenterology.

[33]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[34]  C. Bradbury,et al.  Cross-talk between Histone Modifications in Response to Histone Deacetylase Inhibitors , 2007, Journal of Biological Chemistry.

[35]  S. Boyault,et al.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.

[36]  H. Eguchi,et al.  Risk of Recurrence in a Long-term Follow-up After Surgery in 417 Patients With Hepatitis B- or Hepatitis C-Related Hepatocellular Carcinoma , 2006, Annals of surgery.

[37]  Kairong Cui,et al.  PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. , 2005, Genes & development.

[38]  P. Dallas,et al.  Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. , 2004, The Biochemical journal.

[39]  Yoshiki Murakami,et al.  Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene , 2003, Oncogene.

[40]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[41]  G. Blanck,et al.  Interferon regulatory factor‐2 point mutations in human pancreatic tumors , 2000, International journal of cancer.

[42]  M. Yaniv,et al.  Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex. , 1996, The EMBO journal.

[43]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[44]  C. Bréchot,et al.  Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma , 1990, Nature.

[45]  J. Maller,et al.  Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II , 1988, Nature.

[46]  Christine Pourcel,et al.  Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma , 1980, Nature.